ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Risankizumab trials show higher clinical remission in patients with Crohn’s disease
January 12, 2021Two Phase III trials have shown that two doses of risankizumab met the primary endpoints in patients with Crohn’s disease. -
Janssen’s psoriasis med Tremfya scores long-term safety and efficacy data
October 19, 2020Janssen has announced new open-label extension data for Tremfya, with the treatment continuing to show high rates of skin clearance through nearly five years in moderate to severe plaque psoriasis. -
Innovent Announces First Subject Dosed in Trial of Anti-IL-23 Monoclonal Antibody
September 02, 2020Innovent Biologics announced the Phase I clinical study (CIBI112A101) of recombinant anti-interleukin 23p19 subunit antibody injection (IBI112) has completed the first healthy subject dosing in China.
Pharma Sources Insight January 2025
